BioCryst Pharmaceuticals (BCRX) Earnings Date & Reports

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

BCRX is expected to report earnings to fall 68.53% to 9 cents per share on November 04

BioCryst Pharmaceuticals BCRX Stock Earnings Reports

Q3'26

Est.

$0.09

Q2'26

Beat

by $0.14

Q1'26

Missed

by $3.03

Q4'25

Beat

by $1.08

Q3'25

Beat

by $0.11

The last earnings report on August 05 showed earnings per share of 30 cents, beating the estimate of 15 cents. With 1.63M shares outstanding, the current market capitalization sits at 2.44B.

View a ticker or compare two or three

BCRX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days